EKF Diagnostics Announces Full Year Results and Investor Presentations
Why we think this is neutral
The RNS appears to be a standard regulatory announcement notifying investors of the company's upcoming full year results and investor presentations. There is no mention of any material financial impact or changes to the business, indicating a neutral sentiment impact.
Key Points
- EKF Diagnostics to announce full year 2024 results on March 25, 2025
- Two investor presentations scheduled for March 25, 2025 - one online and one in-person in London
- Presentations will be hosted by Julian Baines, Executive Chair, and Stephen Young, CFO
Summary
The global diagnostics company will announce its full year results and hold investor presentations on March 25, 2025.
EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed global diagnostics business, will announce its full year results for the year ended 31 December 2024, on Tuesday 25 March 2025. The company will hold two investor presentations on the same day, one online via Investor Meet Company and one in-person in London, where the management team will present the results.
Key Dates
March 25, 2025
EKF Diagnostics to announce full year 2024 results and hold investor presentations
GENERAL UPDATE